Power Law company profile

Protagonist Therapeutics

Biotech & Life Sciences · Newark, United States · Founded 2006 · IPO 2016 Unicorn

Develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies

Valuation

$5.80B

Market cap · May/2026

Revenue

$46M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

10 investors on Protagonist Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Starfish Ventures

Lilly Ventures

QIC BioVentures

Series B+ 7 investors entered at this stage

Canaan

Pharmstandard

Foresite Capital

RA Capital Management

The University of Queensland

Johnson & Johnson Development Corporation

Inbio Ventures

Global footprint

Where Protagonist Therapeutics has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States92.3%

🇦🇺 Australia6.8%

🇪🇸 Spain1%

3 countries shown

Web traffic by country

9K monthly visits
across markets

🇺🇸 United States58.9%

🇮🇳 India15.6%

🇬🇧 United Kingdom10%

🇭🇰 Hong Kong5.6%

🇫🇷 France2.2%

Top 5 markets shown

Patent intelligence

$59M patent portfolio · 52 active families

Estimated portfolio value

$59M

1.0% of market cap · 34.6× smaller than top peer Ablynx ($2B)

52 active patent families

Where Protagonist Therapeutics innovates Molecular biologyPeptide inhibitorReceptorWhite blood cellInterleukin

Where Protagonist Therapeutics concentrates vs peers

Each axis is a top-10 topic across Protagonist Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Protagonist Therapeutics

An AI-synthesized read of the highest-engagement posts about Protagonist Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Protagonist Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles